Gene expression profiles of YAP1, TAZ, CRB3, and VDR in familial and sporadic multiple sclerosis among an Iranian population

Abstract Alterations in the regulatory mechanisms that control the process of myelination in the nervous system, may lead to the impaired myelination in the Multiple sclerosis. The Hippo pathway is an important mediator of myelination in the nervous system and might contribute to the pathophysiology...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sheyda Khalilian, Zohreh Hojati, Fariba Dehghanian, Vahid Shaygannejad, Seyedeh Zahra Hosseini Imani, Majid Kheirollahi, Mehdi Khorrami, Omid Mirmosayyeb
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/773a4cc80f744fb28ad2807b63ac856a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:773a4cc80f744fb28ad2807b63ac856a
record_format dspace
spelling oai:doaj.org-article:773a4cc80f744fb28ad2807b63ac856a2021-12-02T14:20:35ZGene expression profiles of YAP1, TAZ, CRB3, and VDR in familial and sporadic multiple sclerosis among an Iranian population10.1038/s41598-021-87131-z2045-2322https://doaj.org/article/773a4cc80f744fb28ad2807b63ac856a2021-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-87131-zhttps://doaj.org/toc/2045-2322Abstract Alterations in the regulatory mechanisms that control the process of myelination in the nervous system, may lead to the impaired myelination in the Multiple sclerosis. The Hippo pathway is an important mediator of myelination in the nervous system and might contribute to the pathophysiology of MS. This study examined via qPCR the RNA expression of YAP1, TAZ, and CRB3 as the key effectors of the Hippo pathway and also, VDR in the peripheral blood of 35 sporadic, 37 familial MS patients; and also 34 healthy first-degree relatives of the familial MS patients (HFR) and 40 healthy individuals without a family history of the disease (control). The results showed the increased expression of VDR in the sporadic group, as compared to other groups. There was also an increased expression of TAZ in the familial and HFR groups, as compared to the control group. The familial and sporadic patients displayed a significantly lower level of expression of YAP1 in comparison to the HFR group. The increased expression level in the sporadic patients and control group, as compared to the HFR group, was seen in CRB3. We also assessed different clinical parameters and MRI characteristics of the patients. Overall, these findings suggest that Hippo pathway effectors and also VDR gene may play a potential role in the pathophysiology of the sporadic and familial forms of MS. Confirmation of different gene expression patterns in sporadic and familial MS groups may have obvious implications for the personalization of therapies in the disease.Sheyda KhalilianZohreh HojatiFariba DehghanianVahid ShaygannejadSeyedeh Zahra Hosseini ImaniMajid KheirollahiMehdi KhorramiOmid MirmosayyebNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Sheyda Khalilian
Zohreh Hojati
Fariba Dehghanian
Vahid Shaygannejad
Seyedeh Zahra Hosseini Imani
Majid Kheirollahi
Mehdi Khorrami
Omid Mirmosayyeb
Gene expression profiles of YAP1, TAZ, CRB3, and VDR in familial and sporadic multiple sclerosis among an Iranian population
description Abstract Alterations in the regulatory mechanisms that control the process of myelination in the nervous system, may lead to the impaired myelination in the Multiple sclerosis. The Hippo pathway is an important mediator of myelination in the nervous system and might contribute to the pathophysiology of MS. This study examined via qPCR the RNA expression of YAP1, TAZ, and CRB3 as the key effectors of the Hippo pathway and also, VDR in the peripheral blood of 35 sporadic, 37 familial MS patients; and also 34 healthy first-degree relatives of the familial MS patients (HFR) and 40 healthy individuals without a family history of the disease (control). The results showed the increased expression of VDR in the sporadic group, as compared to other groups. There was also an increased expression of TAZ in the familial and HFR groups, as compared to the control group. The familial and sporadic patients displayed a significantly lower level of expression of YAP1 in comparison to the HFR group. The increased expression level in the sporadic patients and control group, as compared to the HFR group, was seen in CRB3. We also assessed different clinical parameters and MRI characteristics of the patients. Overall, these findings suggest that Hippo pathway effectors and also VDR gene may play a potential role in the pathophysiology of the sporadic and familial forms of MS. Confirmation of different gene expression patterns in sporadic and familial MS groups may have obvious implications for the personalization of therapies in the disease.
format article
author Sheyda Khalilian
Zohreh Hojati
Fariba Dehghanian
Vahid Shaygannejad
Seyedeh Zahra Hosseini Imani
Majid Kheirollahi
Mehdi Khorrami
Omid Mirmosayyeb
author_facet Sheyda Khalilian
Zohreh Hojati
Fariba Dehghanian
Vahid Shaygannejad
Seyedeh Zahra Hosseini Imani
Majid Kheirollahi
Mehdi Khorrami
Omid Mirmosayyeb
author_sort Sheyda Khalilian
title Gene expression profiles of YAP1, TAZ, CRB3, and VDR in familial and sporadic multiple sclerosis among an Iranian population
title_short Gene expression profiles of YAP1, TAZ, CRB3, and VDR in familial and sporadic multiple sclerosis among an Iranian population
title_full Gene expression profiles of YAP1, TAZ, CRB3, and VDR in familial and sporadic multiple sclerosis among an Iranian population
title_fullStr Gene expression profiles of YAP1, TAZ, CRB3, and VDR in familial and sporadic multiple sclerosis among an Iranian population
title_full_unstemmed Gene expression profiles of YAP1, TAZ, CRB3, and VDR in familial and sporadic multiple sclerosis among an Iranian population
title_sort gene expression profiles of yap1, taz, crb3, and vdr in familial and sporadic multiple sclerosis among an iranian population
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/773a4cc80f744fb28ad2807b63ac856a
work_keys_str_mv AT sheydakhalilian geneexpressionprofilesofyap1tazcrb3andvdrinfamilialandsporadicmultiplesclerosisamonganiranianpopulation
AT zohrehhojati geneexpressionprofilesofyap1tazcrb3andvdrinfamilialandsporadicmultiplesclerosisamonganiranianpopulation
AT faribadehghanian geneexpressionprofilesofyap1tazcrb3andvdrinfamilialandsporadicmultiplesclerosisamonganiranianpopulation
AT vahidshaygannejad geneexpressionprofilesofyap1tazcrb3andvdrinfamilialandsporadicmultiplesclerosisamonganiranianpopulation
AT seyedehzahrahosseiniimani geneexpressionprofilesofyap1tazcrb3andvdrinfamilialandsporadicmultiplesclerosisamonganiranianpopulation
AT majidkheirollahi geneexpressionprofilesofyap1tazcrb3andvdrinfamilialandsporadicmultiplesclerosisamonganiranianpopulation
AT mehdikhorrami geneexpressionprofilesofyap1tazcrb3andvdrinfamilialandsporadicmultiplesclerosisamonganiranianpopulation
AT omidmirmosayyeb geneexpressionprofilesofyap1tazcrb3andvdrinfamilialandsporadicmultiplesclerosisamonganiranianpopulation
_version_ 1718391557260836864